Systemic Lupus Erythematosus
3 competing products in clinical development for Systemic Lupus Erythematosus.
Pipeline by Phase
Phase 11
Phase 1/21
Phase 21
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Baricitinib + Placebo | Eli Lilly | Phase 2 | Completed | 35 |
| DS-7011a + Placebo | Daiichi Sankyo | Phase 1/2 | Completed | 32 |
| DS-7011a + Placebo | Daiichi Sankyo | Phase 1 | Completed | 29 |